Fatpos Global has released a report titled “Digital Therapeutics Market - Analysis of Market Size, Share & Trends for 2021 – 2022 and Forecasts to 2032” which is anticipated to reach 47.2 billion USD by 2032. According to a study by Fatpos Global, the market is expected to portray a CAGR of 26.1% between 2022 and 2032. According to the market research study, the increasing prevalence of chronic diseases that are preventable, the need to reduce healthcare expenditures, the growth of venture capital, and the advantages in digital therapies are expected to boost the growth of the Digital Therapeutics Market.

The market research study on Digital Therapeutics Market includes in-depth insights such as:

• Digital Therapeutics Market in North America held the largest market share in the year 2021.
• Digital Therapeutics Market is classified based on the Type into Devices and Software & Services.
• Digital Therapeutics Market is classified based on the Application into Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases, and Others.
• Digital Therapeutics Market is classified based on the End User into Patients, Providers, Payers, Employers, and Others.
• Growing need to control healthcare -associated prices and rising fundings in digital medicines are expected to boost market growth.

“The introduction of modern digital therapeutics smartphone applications in the industry is promoted by the growing attention of major industry players on regulatory body approvals, which is fueling the Digital Therapeutics Market.”, said a lead analyst at Fatpos Global .

Digital Therapeutics (DTx) is software-driven, factual therapeutic intervention that prevent, treat, or manage medical conditions. These patient-facing software programs come with a demonstrated clinical advantage that supports the management, treatment, and prevention of diseases.

Digital Therapeutics Market is classified based on the End User into Patients, Providers, Payers, Employers, and Others. The Patients category held a greater share of revenue in 2021, and it is predicted to continue dominance during the projected period. This expansion is linked to patients using digital therapeutic solutions more frequently. Therapeutic healthcare programs and applications are mostly used by patients. The expanding demand for digital treatments is backed by an increasing number of individuals being diagnosed with chronic diseases.

Key Players in the Market

Some of the key players operating in the Digital Therapeutics Market are AmerisourceBergen, ResMed, Teladoc Health Inc., Fitbit LLC, Omada Health Inc., Pear Therapeutics Inc., GAIA AG, BigHealth, Welldoc Inc., DarioHealth Corp., Akili Interactive Labs Inc., HYGIEIA, Canary Health, 2Morrow Inc., Limbix Health Inc., and Other Prominent Players.

Get Valuable Insights into Market

In the latest market study conducted by Fatpos Global thrives to present an unbiased analysis of the Digital Therapeutics Market that covers the historical demand data as well as the forecast figures for the period, i.e., 2022-2032. The study includes compelling insights into growth that is witnessed in the Market. Digital Therapeutics Market is classified based on Type into Devices and Software & Services. By Application, the Digital Therapeutics Market is classified based on Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases, and Others. By End User, the Digital Therapeutics Market is classified based on Patients, Providers, Payers, Employers, and Others. Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa.